Accéder au contenu
Merck

The production of [124I]iodine and [86Y]yttrium.

European journal of nuclear medicine and molecular imaging (2011-04-13)
Jochen Schmitz
RÉSUMÉ

The use of paired tracers such as (124)I/(131)I and (86)Y/(90)Y allows pretherapy PET imaging with positron emitting radioisotopes of the same element as used for therapy. Whereas nowadays most therapy nuclides are produced by reactors or generators, the production of the corresponding PET isotopes requires the irradiation of adequate targets using particle accelerators such as cyclotrons. This paper describes the production routes for (124)I and (86)Y.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Tellurium dioxide, ≥99%
Sigma-Aldrich
Strontium carbonate, ≥99.9% trace metals basis
Sigma-Aldrich
Strontium carbonate, ≥98%
Sigma-Aldrich
Tellurium dioxide, 99.995% trace metals basis
Sigma-Aldrich
Strontium carbonate, 99.995% trace metals basis
Sigma-Aldrich
Tellurium dioxide, ≥97.0%